secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001493152-25-003316
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals announces 1-for-100 reverse stock split to meet Nasdaq bid price requirement
--------------------------------------------------------------------------------

- Effective Jan 24, 2025 at 5pm ET; shares begin trading on split-adjusted basis Jan 27 under ticker CDT.
- Every 100 shares combined into 1; no fractional shares; cash in lieu for fractional interests.
- Post-split outstanding shares reduced to approximately 1.5 million.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315225003316/0001493152-25-003316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315225003316/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer